XCath
PrivateLast Round
Series C
Mar 12, 2026
Total Funding Raised
$35.33M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
XCath operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Series C round in March 2026.
XCath is a medical device company that develops next-generation endovascular robotics and steerable neurovascular guidewires for the minimally invasive treatment of complex vascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XCath Comparables
Compare XCath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sentante | 86% | |
| Remedy Robotics | 85% | |
| Magnendo | 79% |
For institutional investors. Book with your work email.
XCath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 12, 2026 | ||||
| Series A | Mar 8, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
XCath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CE-Ventures | Series A |
| Crescent Enterprises | Series A, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2026
Grew 16% QoQ, from 32 to 37 employees.
- May 16, 2026
Monthly visitors grew 84% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 16, 2026
XCath Inc is due to release a documentary about Operation Robo Angel in Oct '26.
For institutional investors. Book with your work email.
XCath Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about XCath's valuation, stock price, and market status.
Is XCath a public or private company?
XCath is a private company.
What is the current stock price of XCath?
XCath is a private company, so its shares have no public market price. Caplight tracks XCath's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is XCath worth (valuation)?
Valuation information for XCath is not publicly available.
Can I buy XCath stock?
XCath shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was XCath's last funding round?
XCath's most recent funding round was Series C on March 12, 2026.
Who are the main investors in XCath?
Key investors in XCath include CE-Ventures, Crescent Enterprises.
Will XCath IPO soon?
No public IPO plans have been announced for XCath.
How can I track XCath secondary market activity?
Caplight tracks bids, offers, and trades in XCath's shares on secondary markets.